U.S. markets open in 2 hours 57 minutes

  • S&P Futures

    4,076.00
    -8.75 (-0.21%)
     

  • Dow Futures

    32,553.00
    -28.00 (-0.09%)
     

  • Nasdaq Futures

    12,507.00
    -53.25 (-0.42%)
     

  • Russell 2000 Futures

    1,831.00
    -6.20 (-0.34%)
     

  • Crude Oil

    113.88
    +1.48 (+1.32%)
     

  • Gold

    1,817.00
    -1.90 (-0.10%)
     

  • Silver

    21.72
    -0.03 (-0.14%)
     

  • EUR/USD

    1.0526
    -0.0029 (-0.27%)
     

  • 10-Yr Bond

    2.9680
    0.0000 (0.00%)
     

  • Vix

    26.32
    -1.15 (-4.19%)
     

  • GBP/USD

    1.2416
    -0.0076 (-0.61%)
     

  • USD/JPY

    129.0830
    -0.2750 (-0.21%)
     

  • BTC-USD

    30,006.72
    -555.66 (-1.82%)
     

  • CMC Crypto 200

    673.89
    +431.21 (+177.69%)
     

  • FTSE 100

    7,520.98
    +2.63 (+0.03%)
     

  • Nikkei 225

    26,911.20
    +251.45 (+0.94%)
     
Webinar:

Yahoo Finance Plus presents 'Investing in the new high-inflation, slowing-growth paradigm'

Analyst Callie Cox joins Jared Blikre to help investors find opportunities in a tough market on Wed, May 18 at 2pm ET.

See why Craig-Hallum Is Bullish On iSpecimen

  • Oops!
    Something went wrong.
    Please try again later.
Vandana Singh
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • ISPC

Craig-Hallum initiated coverage of iSpecimen Inc (NASDAQ: ISPC) with a Buy rating and $20 price target.

  • "Much the way Amazon has become the go-to platform for buyers and sellers of consumer goods," the analyst believes iSpecimen can become the go-to platform for human biospecimens, writes analyst Matthew Hewitt.

  • The analyst notes that though the Company was founded in 2009, it has only recently reached a critical mass of buyers and sellers, with revenue for 2021 on track to be nearly triple the 2019 level.

  • Related: iSpecimen Stock Rallies On Supply Pact Of Human Biospecimens For COVID-19 Research.

  • The Company offers a range of biofluids, tissue, and stem and immune cells, including specimens with genetic variants (such as COVID-19 variants).

  • Recently, iSpecimen expanded its global supplier network, with 25% of its newest specimen suppliers in 2021 coming from outside the U.S.

  • Throughout 2021, iSpecimen has added nearly two dozen biospecimen suppliers to its network across the U.S., Europe, and Asia-Pacific.

  • In December, iSpecimen expanded its global biospecimen provider network to support research related to neurological disorders.

  • Price Action: ISPC shares are up 7.20 at $8.64 during the market session on the last check Tuesday.

Latest Ratings for ISPC

Jan 2022

Craig-Hallum

Initiates Coverage On

Buy

Nov 2021

EF Hutton

Maintains

Buy

View More Analyst Ratings for ISPC
View the Latest Analyst Ratings

See more from Benzinga

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Recommended Stories

  • ‘It’s so horrible that I want to buy it’ — Jim Cramer likes these 2 beaten-down tech names that are still posting white-hot revenue growth

    High-quality items seldom go on sale. Grab them when they do.

  • Warren Buffett says these are the best stocks to own when inflation spikes — with consumer prices still surging, it's time to follow his lead

    The Oracle of Omaha knows how to beat inflation. So ride his coattails.

  • Billionaire George Soros Bets on These 3 ‘Strong Buy’ Stocks

    Keeping up the returns would be a neat trick in today’s market, as the main indexes are all steeply down for the year so far – with losses of 15% on the S&P 500 and 24% on the NASDAQ. For investors, then, the best strategy may just be to follow a winner. Billionaire investing legend George Soros is most definitely a winner. He’s built a portfolio worth billions, and had possibly the greatest bull run in hedge fund history, averaging 30% annualized returns for 30 years. Starting in 1992, when he

  • Why Upstart Holdings and Global-e Online Soared on Tuesday

    Investors instead looked at the massive declines in stocks over the first four months of 2022 and concluded that even with some reasons for worry, the downturn had been too fast. Both Upstart Holdings (NASDAQ: UPST) and Global-e Online (NASDAQ: GLBE) were up quite strongly on the day, and shareholders seem to be having a change of heart after having been extremely negative on the high-growth companies ' prospects recently. Shares of Upstart Holdings jumped 23% on Tuesday.

  • 3 top dividend stocks yielding as high as 8.7% — with inflation still near 40-year highs, it might be a good move to nail down some income

    Inflation remains white-hot. These stocks can help ease the pain.

  • Crypto Rout: Another Stablecoin Falls After UST and Luna

    Cryptocurrency prices undermined by fears of recession. Tokens, which are supposed to reduce volatility, are collapsing.

  • Why Nio Stock Just Rocketed by More Than 9%

    In just two days, Chinese electric vehicle manufacturer Nio (NYSE: NIO) is scheduled to report its first-quarter earnings-- at least, according to Nasdaq.com, it is. The company hasn't officially announced its release date yet, and other financial data providers point out that, seeing as Nio reported its Q1 earnings on May 28 in two of the past three years, it's more likely to report closer to that date this year as well. Is there a good reason to buy Nio stock ahead of earnings?

  • Living Off Dividends in Retirement: 10 Best Stocks To Consider

    In this article, we discuss 10 best stocks to consider for retirement. If you want to see more dividend stocks in this selection, click Living Off Dividends in Retirement: 5 Best Stocks To Consider. The average age of retirement in the United States is 62, and American retirees represent a significant proportion of the adult […]

  • Investors Who Shorted Russia ETFs Are Now Stuck Paying Never-Ending Fees

    (Bloomberg) -- Investors who bet against ETFs tracking Russian assets in the build up to the Ukraine invasion made the right call -- and they’ve been paying the price ever since.Most Read from BloombergOnetime Richest Singapore Tycoon Has Lost 80% of His FortuneMeet the Hedge-Fund Manager Who Warned of Terra’s $60 Billion ImplosionOmicron Is Turning Out to Be a Weak VaccineElon Musk Says Twitter Must Prove Bot Claims for $44 Billion Deal to ProceedMicrosoft Will Boost Pay and Stock Compensation

  • Walmart Gets Hammered by Worst Drop Since 1987 on Forecast Cut

    (Bloomberg) -- Walmart Inc. tumbled the most in almost 35 years after cutting its full-year profit forecast due to inflationary pressures, especially in food and fuel.Most Read from BloombergOnetime Richest Singapore Tycoon Has Lost 80% of His FortuneWalmart Flashes a Warning Sign to the Entire Consumer EconomyElon Musk Has a Bigger Problem Than Twitter Bots: A Huge Debt BurdenUS Set to Block Russian Debt Payments, Raising Default OddsElon Musk Does Not Care About Spam BotsThe worsening outlook

  • Jamie Dimon Dealt Rare Blow as JPMorgan Holders Reject Pay Plan

    (Bloomberg) -- Jamie Dimon was handed a rare defeat from shareholders as they rejected a pay proposal, just months after the board unfurled lucrative incentives for the JPMorgan Chase & Co. chief to stay on for a number of years.Most Read from BloombergUS Set to Block Russian Debt Payments, Raising Default OddsOnetime Richest Singapore Tycoon Has Lost 80% of His FortuneWalmart Flashes a Warning Sign to the Entire Consumer EconomyElon Musk Has a Bigger Problem Than Twitter Bots: A Huge Debt Burde

  • Sundial Growers Inc (SNDL) Q1 2022 Earnings Call Transcript

    Yesterday, Sundial issued a press release announcing their financial results for the first quarter ended on March 31, 2022. Sundial has also posted a supplemental investor presentation found on the sndlgroup.com website. Presenting on this morning's call, we have Zach George, chief executive officer; Jim Keough, chief financial officer; and Andrew Stordeur, president and chief operating officer.

  • Stock market news live updates: Stock futures rise to extend gains after Powell comments

    U.S. stock futures opened higher Tuesday afternoon after rallying during the regular trading day, as investors took in reassurances from Federal Reserve Chair Jerome Powell that the central bank was set on using its policies to bring down inflation still running at multi-decade highs.

  • Ray Dalio's Bridgewater dumps Tesla, bets on meme stocks AMC and GameStop

    Ray Dalio's Bridgewater Associates, the world's largest hedge fund, has parted ways with its stake in Tesla and placed new bets on meme-stocks AMC and GameStop during the first quarter.

  • Could Novavax's Next Step Make It a Multibagger?

    Novavax disappointed investors when its regulatory submissions fell behind. Now, all eyes are on Novavax's next step: winning authorization in the U.S. Could this nudge the stock out of its slump -- and even turn it into a multibagger? Novavax reported revenue of $704 million and net income of $203 million.

  • Energy Transfer's Perseverance Is About to Pay Off Big Time

    Energy Transfer (NYSE: ET) has a long history of developing infrastructure projects to support growing energy demand. The company has built thousands of miles of pipelines, multiple oil and gas processing facilities, and several storage and export terminals over the years. The master limited partnership (MLP) currently expects to invest upwards of $2.1 billion this year in expanding its energy infrastructure network.

  • Why Nvidia Stock Shot Higher on Tuesday

    Down Thursday, up Friday, down Monday -- seesawing semiconductor stock Nvidia (NASDAQ: NVDA) played true to form on Tuesday, rising once again, and this time by a pretty significant number, closing the day up 5.3%. Tuesday did start off well for Nvidia stock, with investment bank Piper Sandler saying it is "moving to a more positive stance" on semiconductor stocks in general, after making some pessimistic comments about the sector two weeks ago. On the one hand, rumblings of weakness in PC sales and worries over whether GPU demand can hold up in the context of a crypto sell-off, combined with more general concerns about rising interest rates and inflation, have investors feeling nervous about semiconductor growth estimates.

  • Elon Musk seems to be ‘looking for a scapegoat’ in Twitter bid, analyst says

    Some analysts think Tesla CEO Elon Musk is just looking for a scapegoat to walk away from the $44 billion Twitter deal or negotiate a lower price.

  • US Set to Block Russian Debt Payments, Raising Default Odds

    (Bloomberg) -- The Biden administration is poised to fully block Russian bond payments to US investors after a deadline expires next week, a move that could force Moscow into its first foreign default in a century.Most Read from BloombergUS Set to Block Russian Debt Payments, Raising Default OddsOnetime Richest Singapore Tycoon Has Lost 80% of His FortuneWalmart Flashes a Warning Sign to the Entire Consumer EconomyElon Musk Has a Bigger Problem Than Twitter Bots: A Huge Debt BurdenElon Musk Does

  • ‘Greedy When Others are Fearful’: Warren Buffett’s 8 New Stock Picks in 2022

    In this article, we discuss Warren Buffett’s 8 new stock picks in 2022. If you want to read about some more Buffett stock picks, go directly to ‘Greedy When Others are Fearful’: Warren Buffett’s 4 New Stock Picks in 2022. There are few value investors who have accumulated as much fame as Warren Buffett of […]